Demographic and clinical characteristics of patients with leukemia and healthy individuals
| Variables | ALL (n=72) | Control (n=72) | P value | AML (n=37) | Control (n=37) | P value | |
| Sex | Boy | 46 (63.9%) | 45 (62.5%) | 0.863 | 21 (56.8%) | 20 (54.1%) | 0.815 |
| Girl | 26 (36.1%) | 27 (37.5%) | 16 (43.2%) | 17 (45.9%) | |||
| Age (year) | 14.33±3.36 | 14.06±3.29 | 0.783 | 29.72±3.89 | 28.32±3.60 | 0.112 | |
| BMI (kg/m2) | 23.50±3.54 | 22.55±3.66 | 0.114 | 25.63±3.21 | 25.49±4.39 | 0.882 | |
| Stage | M0 | None | None | 2 (5.4%) | None | ||
| M1 | None | None | 2 (5.4%) | None | |||
| M2 | None | None | 5 (13.5%) | None | |||
| M3 | None | None | 6 (16.2%) | None | |||
| M4 | None | None | 16 (43.2%) | None | |||
| M5 | None | None | 6 (16.2%) | None | |||
| L1 | 34 (47.2%) | None | None | None | |||
| L2 | 27 (37.5%) | None | None | None | |||
| L3 | 11 (15.3%) | None | None | None | |||
| WBC (×109/L) | 43.87±18.73 | 6.82±1.52 | <0.001* | 49.75±16.77 | 6.74±1.64 | <0.001* | |
| Platelets (×109/L) | 63.06±44.61 | 360.5±54.52 | <0.001* | 57.56±39.08 | 357.4±54.37 | <0.001* | |
| Hb (g/L) | 9.23±1.08 | 14.61±1.12 | <0.001* | 9.21±1.02 | 14.46±1.06 | <0.001* | |
| CHOL (mg/dL) | 224.45±56.23 | 171.40±38.28 | <0.001* | 230.05±55.86 | 179.13±40.72 | 0.001* | |
| TG (mg/dL) | 219.63±54.88 | 156.73±37.98 | <0.001* | 220.24±54.89 | 155.48±36.92 | 0.001* | |
| HDL (mg/dL) | 42.13±13.67 | 49.35±13.02 | 0.001* | 44.40±12.37 | 48.96±12.72 | 0.123 | |
| LDL (mg/dL) | 127.05±43.63 | 95.31±38.99 | <0.001* | 127.89±38.97 | 103.60±40.83 | 0.011* | |
Comparisons were made by using the χ2 test and independent sample t-test.
*P˂0.05.
ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; BMI, body mass index; CHOL, cholesterol; Hb, hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides; WBC, white blood cell.